VG Life Sciences Inc.
VGLS
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -1.01M | -1.40M | -1.46M | -424.50K | -1.06M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 205.40K | 375.80K | 671.40K | 599.10K | 518.00K |
| Total Other Non-Cash Items | 425.80K | 448.50K | 479.30K | 336.00K | 400.60K |
| Change in Net Operating Assets | 333.80K | 336.50K | 146.80K | -917.90K | -323.90K |
| Cash from Operations | -48.30K | -237.60K | -165.00K | -407.40K | -468.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 86.20K | 234.00K | 189.00K | 409.20K | 494.20K |
| Total Debt Repaid | -19.30K | -27.90K | -27.90K | -21.60K | -4.80K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 5.70K | -- | -- | -- |
| Cash from Financing | 66.90K | 211.80K | 161.10K | 387.60K | 489.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.60K | -25.70K | -3.90K | -19.90K | 21.00K |
